← Back to OTLK

Outlook Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 18/08/2026Mar 2026Filed 18/08/2026Dec 2025Filed 18/08/2026Jun 2025Filed 18/08/2026Mar 2025Filed 18/08/2026Dec 2024Filed 18/08/2026Jun 2024Filed 14/08/2025Mar 2024Filed 14/08/2025
$1.5
−$20−$4.5−$23−$20−$46$17$44−$114
−$0.15−$0.05−$0.38−$0.55−$1.50$0.72−$0.89−$8.01
13782603731242514

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.